Using health state utility values in models exploring the cost-effectiveness of health technologies

Value in Health

Volumn 15, Issue 6, 2012, Pages 971-974

  Ara, Roberta ^a   Wailoo, Allan ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

EQ 5D; quality of life; SF 36; utility

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACCURACY; ANALYTIC METHOD; ARTHRITIS; ARTICLE; CINAHL; COCHRANE LIBRARY; COMORBIDITY; CONSENSUS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; EMBASE; EUROQOL FIVEDIMENSIONAL QUESTIONNAIRE; EVIDENCE BASED PRACTICE; EXPLORATORY RESEARCH; FIBROMYALGIA; HEALTH CARE POLICY; HEALTH STATUS; HEALTH SURVEY; HEALTH UTILITIES INDEX 3 QUESTIONNAIRE; HUMAN; INFLUENZA; INFORMATION PROCESSING; MATHEMATICAL MODEL; MEDLINE; METHODOLOGY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; POPULATION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; RHEUMATIC DISEASE; SAMPLE SIZE; SCIENTIFIC LITERATURE; SHORT FORM 36; SHORT FORM SIX D; TECHNOLOGY; UNCERTAINTY; VALIDATION PROCESS;

BIOMEDICAL TECHNOLOGY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH STATUS; HUMANS; MODELS, ECONOMIC; POLICY MAKING; QUALITY-ADJUSTED LIFE YEARS;

EID: 84866400508     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.05.003     Document Type: Article

References (40)

1. National Institute for Health and Clinical Excellence Guide to the methods of technology appraisal (updated June 2008) www.nice.org.uk [Accessed January 30, 2012]
2. M.R. Gold Panel on cost-effectiveness in health and medicine Med Care 34 12, Suppl. 1996 DS197 DS199
3. A.H. Briggs Handling uncertainty in cost-effectiveness models Pharmacoeconomics 17 2000 479 500
4. A.R. Willan, A.H. Briggs Statistical Analysis of Cost-Effectiveness Data (Ebooks Corporation ed.) 2006 John Wiley Chichester, West Sussex, UK
5. R. Ara, A.J. Wailoo NICE DSU Technical Support Document 12: the use of health state utility values in decision models http://www.nicedsu.org.uk [Accessed January 30, 2012]
6. F. van Nooten, G.M. Davies, J.W. Jukema Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia Netherlands Heart J 19 2011 61 67
7. R. Ara, J. Brazier Populating an economic model with health state utility values: moving towards better practice Value Health 13 2010 509 518
8. R. Ara, J.E. Brazier Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available Value Health 14 2011 539 545
9. D.G. Fryback, W.F. Lawrence Dollars may not buy as many QALYs as we think Med Decis Making 17 1997 276
10. N. Bansback, R. Ara, S. Ward Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health states Pharmacoeconomics 26 2008 395 408
11. P.W. Sullivan, V. Ghushchyan Preference-based EQ-5D index scores for chronic conditions in the United States Med Decis Making 26 2006 410 420
12. R. Ara, J. Brazier Estimating health state utility values for comorbid health conditions using SF-6D data Value Health 14 2011 740 745
13. R. Ara, A.J. Wailoo Estimating health state utility values for comorbid health conditions: a synopsis of the current evidence base http://eprints. whiterose.ac.uk/ [Accessed January 30, 2012]
14. C.N. McIntosh Utility scores for comorbid conditions: methodological issues and advances Handbook of Disease Burdens and Quality of Life Measures 2010 Springer New York
15. B. Hu, A.Z. Fu Predicting utility for joint health states: a general framework and a new nonparametric estimator Med Decis Making 30 2010 E29
16. A. Basu, W. Dale, A. Elstein A linear index for predicting joint health states utilities from single health states utilities Health Econ 18 2009 403 419
17. R. Ara, J. Brazier Comparing EQ-5D scores for comorbid health conditions estimated using five different methods Med Care 50 2012 452 459
18. W. Dale What is the best model for estimating joint health states utilities? Comparing the linear index model to the proportional decrement model Med Decis Making 30 2010 531 533
19. N.F. Esnaoloa, D.A. Doherty, M.L. Johnson Comparison of additive and multiplicative utility predictions to predict the utilities of combined health states: abstracts from the 23rd Annual Meeting of the Society of Medical Decision Making Med Decis Making 21 2001 517
20. W. Dale, A. Basu, A. Elstein Predicting utility ratings for joint health states from single health states in prostate cancer: empirical testing of 3 alternative theories Med Decis Making 28 2008 102
21. M. Janssen, G. Bonsel Estimating preference weights for chronic multimorbidity: don't add, multiply www.euroqol.org [Accessed January 30, 2012]
22. A.Z. Fu, M. Katan Utilities should not be multiplied Med Care 46 2008 984 990
23. J. Hanmer, D. Vanness, R. Gangnon Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions J Clin Epidemiol 63 2010 331 441
24. H. Wee, Y. Cheung, S. Li The impact of diabetes mellitus and other chronic medical conditions on health related quality of life: is the whole greater than the sum of its parts? Health Qual Life Outcomes 3 2005 2
25. W. Flanagan, C.N. McIntosh, C. Le Petit Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores Popul Health Metrics 4 2006 13
26. ICTDR Investigator Manual: Monitoring and reporting adverse events: appendices http://www.icssc.org/Documents/Resources/ AEManual2003AppendicesFebruary-06-2003%20final.pdf [Accessed January 30, 2012]
27. D. Craig, C. McDaid, T. Fonseca Are adverse effects incorporated in economic models? A survey of current practice Int J Technol Assess Health Care 26 2010 323 329
28. J.C. Tosh, L.J. Longworth, E. George Utility values in National Institute for Health and Clinical Excellence (NICE) technology appraisals Value Health 14 2011 102 109
29. K. Claxton, M. Sculpher, C. McCabe Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra Health Econ 14 2005 339 347
30. B.A. Van Hout, M.J. Al, G.S. Gordon Costs, effects and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
31. E. Fenwick, K. Claxton, M. Sculpher Representing uncertainty: the role of cost-effectiveness acceptability curves Health Econ 10 2001 779 787
32. G.C. Critchfield, K.E. Willard Probabilistic analysis of decision trees using Monte Carlo simulation Med Decis Making 6 1986 85
33. P. Doubilet, C.B. Begg, M.C. Weinstein Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach Med Decis Making 5 1985 157
34. A.H. Briggs, A.M. Gray Handling uncertainty in economic evaluations of healthcare interventions BMJ 319 1999 635 638
35. L.J. Longworth, D. Chandiwana, P. Kandaswamy Report to the NICE Methods Review Working Party: key issues arising from workshop on health-related utility measurement http://www.nice.org.uk/media/4A6/59/UtilitiesBriefingPaper010607KT. pdf [Accessed January 30, 2012]
36. M. Hernández Alava, A.J. Wailoo, R. Ara Tails from the Peak District: adjusted censored mixture models of EQ-5D health state utility values Value Health 14 2012 550 561
37. J. Brazier, J. Ratcliffe Measuring and Valuing Health Benefits for Economic Evaluation 2007 Oxford University Press Oxford, UK
38. L. Longworth, D. Rowen NICE DSU Technical Support Document 10: the use of mapping methods to estimate health state utility values http://www.nicedsu.org. uk [Accessed January 30, 2012]
39. J.E. Brazier, Y. Yang, A. Tsuchiya A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
40. M. Palta, H. Chen, R.M. Kaplan Standard error of measurement of 5 health utility indexes across the range of health for use in estimating reliability and responsiveness Med Decis Making 31 2011 260 269